-
-
-
Congress focused on Medicare reform in June, with both the House and Senate passing their own versions of a Medicare prescription drug program.
-
In addition to the Senate bill, the U.S. Food and Drug Administration (FDA) announced regulations in mid-June that would streamline the process for making generic drugs available to consumers.
-
Growth in prescription drug spending for the first quarter of 2003 slowed in part to increased usage of generic drugs, says pharmacy benefit manager Express Scripts of St. Louis.
-
A recent study shows that finasteride (Proscar) prevents or delays the appearance of prostate cancer. The drug, however, also shows sexual side effects and an increased risk of high-grade prostate cancer.
-
Omeprazole (Prilosec) approved for OTC heartburn treatment; Recall includes all repacked atorvastatin products; Paroxetine (Paxil) should not be used in children; FDA announces pilot program to post warning letter responses
-
These drugs recently received final approval from the U.S. Food and Drug Administration (FDA):
-
-
In other legislation favorable to pharmacists, the Senate Committee on Health, Education, Labor, and Pensions recently passed a bipartisan bill that would provide two student loan repayment programs for certain pharmacists. The bill now moves on to the Senate floor for consideration.
